A PK/PD study on antihyperalgesia by an α2/3-GABA receptor PAM in mice: Lack of tolerance liability and potential involvement of γ1-GABA receptors

Background and purpose: GABA receptors (GABARs) are heteropentameric ion channels that control almost all CNS functions, including spinal nociception. Most GABARs contain a γ2 subunit but differ in their α and β subunit composition. TPA023B is an α2/α3 subtype selective, non-sedative, positive allosteric modulator (PAM) with antihyperalgesic activity in rodents. The pharmacokinetic/pharmacodynamic (PK/PD) characteristics of its antihyperalgesic action are unknown. Experimental approach: To establish the PK/PD relationship for the antihyperalgesic effects of TPA023B, blood and brain concentrations, and brain and spinal cord receptor occupancies (RO) were determined at various time points following the administration of single oral doses of TPA023B in mice, and correlated with the antihyperalgesic effects (increases in paw withdrawal thresholds to punctate mechanical stimuli). In addition, the potentiating effects of TPA023B on recombinant γ1- and γ2-containing GABARs (γ1-GABARs and γ2-GABARs, respectively) were determined in electrophysiological (patch-clamp) and fluorometric (membrane potential-sensitive dye) assays. Key results: Antihyperalgesic effects of TPA023B correlated well with blood and brain concentrations, and no signs of tolerance (clockwise hysteresis) were observed. However, antihyperalgesia did not correlate with receptor occupancy at γ2-GABARs, suggesting that a relevant part of the antihyperalgesic action occurred through non-γ2-GABARs. In this regard, experiments in heterologous expression systems revealed that TPA023B not only potentiates γ2 but also γ1 containing GABARs. Conclusions and implications: Antihyperalgesic effects of TPA023B do not undergo tolerance development. Besides γ2-GABARs, γ1-GABARs appear to contribute to the antihyperalgesic effects of TPA023B. γ1-GABAR selective PAMs may hence have a therapeutic potential in chronic pain conditions.

Authors

Publication Details

Journal
Universität Zürich, ZORA
Published
2026-01-06
DOI
https://doi.org/10.5167/uzh-292423
Primary Topic
Neuroscience and Neuropharmacology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A PK/PD study on antihyperalgesia by an α2/3-GABA receptor PAM in mice: Lack of tolerance liability and potential involvement of γ1-GABA receptors

Thomas Grampp, M. Oana Popa, Thomas Hathaway, Marcus Hanley et al.
Universität Zürich, ZORA
Neuroscience and Neuropharmacology Research
article

A PK/PD study on antihyperalgesia by an α2/3-GABA receptor PAM in mice: Lack of tolerance liability and potential involvement of γ1-GABA receptors

Thomas Grampp, M. Oana Popa, Thomas Hathaway, Marcus Hanley, Daniel Ulrich, Karen T Elvers, Gui Jie Feng, Elena Neumann, Misa Oyama, Dietmar Benke, William T Ralvenius, Hanns Ulrich Zeilhofer, John R Atack
article en

Abstract

Background and purpose: GABA receptors (GABARs) are heteropentameric ion channels that control almost all CNS functions, including spinal nociception. Most GABARs contain a γ2 subunit but differ in their α and β subunit composition. TPA023B is an α2/α3 subtype selective, non-sedative, positive allosteric modulator (PAM) with antihyperalgesic activity in rodents. The pharmacokinetic/pharmacodynamic (PK/PD) characteristics of its antihyperalgesic action are unknown. Experimental approach: To establish the PK/PD relationship for the antihyperalgesic effects of TPA023B, blood and brain concentrations, and brain and spinal cord receptor occupancies (RO) were determined at various time points following the administration of single oral doses of TPA023B in mice, and correlated with the antihyperalgesic effects (increases in paw withdrawal thresholds to punctate mechanical stimuli). In addition, the potentiating effects of TPA023B on recombinant γ1- and γ2-containing GABARs (γ1-GABARs and γ2-GABARs, respectively) were determined in electrophysiological (patch-clamp) and fluorometric (membrane potential-sensitive dye) assays. Key results: Antihyperalgesic effects of TPA023B correlated well with blood and brain concentrations, and no signs of tolerance (clockwise hysteresis) were observed. However, antihyperalgesia did not correlate with receptor occupancy at γ2-GABARs, suggesting that a relevant part of the antihyperalgesic action occurred through non-γ2-GABARs. In this regard, experiments in heterologous expression systems revealed that TPA023B not only potentiates γ2 but also γ1 containing GABARs. Conclusions and implications: Antihyperalgesic effects of TPA023B do not undergo tolerance development. Besides γ2-GABARs, γ1-GABARs appear to contribute to the antihyperalgesic effects of TPA023B. γ1-GABAR selective PAMs may hence have a therapeutic potential in chronic pain conditions.

Universität Zürich, ZORA
Openalex Percentile: Top 45%
Neuroscience and Neuropharmacology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.